The Bruker MALDI Biotyper Solution Receives AOAC International Approvals for Two Official Methods of Analysis (OMA) in Food Microbiology

Bruker is pleased to announce that AOAC International has approved the MALDI Biotyper solution for two new Official Methods of Analysis (OMA) for the confirmation and identification of pathogenic and non-pathogenic bacteria. The two methods include some of the most common food pathogens, including Salmonella spp (spp means all species of the genus Salmonella), Cronobacter spp, Listeria spp and Listeria monocytogenes, as well as the identification of other Gram-negative and Gram-positive bacteria.

2018年2月 9日

Bruker Corporation to Present at the LEERINK Partners 7th Annual Global Healthcare Conference

2018年2月 8日

Bruker Reports Fourth Quarter and Fiscal Year 2017 Financial Results

BILLERICA, Mass., Feb. 8, 2018 /PRNewswire/ -- Bruker Corporation (NASDAQ: BRKR) today announced financial results for its fourth quarter and fiscal year ended December 31, 2017. Bruker's revenues for the fourth quarter of 2017 were $530.5 million, an increase of 12.8% compared to the fourth quarter of 2016. In the fourth quarter of 2017, Bruker's year-over-year organic revenue growth was 4.0%, while growth from acquisitions was 3.6%, and the favorable effect from changes in foreign currency rates was 5.2%.

2018年1月 2日

Bruker Corporation to Present at the 36th Annual J.P. Morgan Healthcare Conference